Ultragenyx Pharmaceu (RARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 227,272 | 100,488 | 60,868 | 91,212 | 159,772 |
| Marketable Securities | 314,616 | 134,005 | 310,659 | 308,897 | 265,689 |
| Receivables | 3,671 | 5,172 | N/A | N/A | N/A |
| Inventories | 2,068 | 757 | N/A | N/A | N/A |
| TOTAL | $581,580 | $269,583 | $390,903 | $419,794 | $444,685 |
| Non-Current Assets | |||||
| PPE Net | 20,830 | 21,837 | 16,030 | 16,405 | 16,517 |
| Investments And Advances | 29,907 | 9,975 | 24,964 | 57,802 | 80,862 |
| Intangibles | 181,528 | 185,951 | 0 | 0 | 0 |
| Other Non-Current Assets | 3,505 | 3,407 | 3,150 | 3,541 | 3,758 |
| TOTAL | $235,770 | $221,170 | $44,144 | $77,748 | $101,137 |
| Total Assets | $817,350 | $490,753 | $435,047 | $497,542 | $545,822 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,569 | 8,886 | 9,288 | 11,876 | 8,345 |
| Accrued Expenses | 49,291 | 62,128 | 54,278 | 50,130 | 42,773 |
| TOTAL | $57,583 | $71,014 | $64,261 | $62,675 | $51,755 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 723 | N/A | 695 | 669 | 637 |
| Other Non-Current Liabilities | 4,944 | 5,119 | 5,228 | 5,414 | 5,589 |
| TOTAL | $36,110 | $36,285 | $5,228 | $5,414 | $5,589 |
| Total Liabilities | $93,693 | $107,299 | $69,489 | $68,089 | $57,344 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 49,772 | 49,606 | 42,589 | 42,458 | 42,313 |
| Common Shares | 50 | 44 | 42 | 42 | 42 |
| Retained earnings | -802,419 | -832,672 | -750,941 | -671,714 | -598,823 |
| Other shareholders' equity | -946 | -5,680 | -7,404 | -4,223 | 231 |
| TOTAL | $723,657 | $383,454 | $365,558 | $429,453 | $488,478 |
| Total Liabilities And Equity | $817,350 | $490,753 | $435,047 | $497,542 | $545,822 |